GLP-1 and Hyperoxia for Organ Protection in Heart Surgery

NCT02673931 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

1400

Enrollment

OTHER

Sponsor class

Conditions

Coronary Disease
Shock, Cardiogenic
Renal Failure
Stroke
Brain Injury
Aortic Valve Disease

Interventions

DRUG: Byetta (Lilly, Exenatide)
DRUG: Conoxia (AGA, oxygen)
DRUG: 20% Human Albumin

Sponsor

Rigshospitalet, Denmark